Calmodulin inhibitors modify cell surface changes triggered by a tumor promoter
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 98 (3), 829-835
- https://doi.org/10.1016/0006-291x(81)91186-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Inhibition of epidermal growth factor binding to cultured mouse epidermal cells by tumor promotersCarcinogenesis: Integrative Cancer Research, 1980
- Studies on the mechanism by which a tumor promoter inhibits binding of epidermal growth factor to cellular receptorsCarcinogenesis: Integrative Cancer Research, 1980
- α-Tocopherol inhibits 12−O-tetradecanoylphorbol-13-acetate-stimulated deacylation of cellular lipids, prostaglandin production, and changes in cell morphology of madin-darby canine kidney cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Specific binding of phorbol ester tumor promoters to mouse skinCell, 1980
- Intracellular phospholipases ABiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1980
- Divalent cation effects in the interaction of the tumor promoter phorbol myristate acetate with rat liver plasma membranesChemico-Biological Interactions, 1979
- Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cellsBiochemical and Biophysical Research Communications, 1979
- Calmodulin stimulates human platelet phospholipase A2Biochemical and Biophysical Research Communications, 1979
- Binding of epidermal growth factor to primary and permanent cultures of mouse epidermal cells: Inhibition by tumor-promoting phorbol estersCancer Letters, 1979
- Calcium‐dependent stimulation of BALB/c 3T3 mouse cell DNA synthesis by a tumor‐promoting phorbol ester (PMA)Journal of Cellular Physiology, 1976